NCT01365338View on ClinicalTrials.gov

A Study To Assess Effects Of PF-04958242 On Bold Functional Magnetic Resonance Imaging During Working Memory Activation And Arterial Spin Labeling At Rest In Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

112

Participants

Timeline

Start Date

June 24, 2011

Primary Completion Date

December 14, 2012

Study Completion Date

December 14, 2012

Conditions
Healthy Volunteer
Interventions
DRUG

Placebo

Administered as specified in the treatment arm

DRUG

PF-04958242

Administered as specified in the treatment arm

Trial Locations (2)

06511

Research Site, New Haven

06519

Research Site, New Haven

Sponsors

Lead Sponsor

Biogen
All Listed Sponsors
collaborator

Yale University

OTHER

lead

Biogen

INDUSTRY

NCT01365338 - A Study To Assess Effects Of PF-04958242 On Bold Functional Magnetic Resonance Imaging During Working Memory Activation And Arterial Spin Labeling At Rest In Healthy Subjects | Biotech Hunter | Biotech Hunter